186 related articles for article (PubMed ID: 12472763)
1. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
Goodman WG; Jüppner H; Salusky IB; Sherrard DJ
Kidney Int; 2003 Jan; 63(1):1-11. PubMed ID: 12472763
[TBL] [Abstract][Full Text] [Related]
2. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
Goodman WG
Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
[TBL] [Abstract][Full Text] [Related]
3. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
Goodman WG
Blood Purif; 2003; 21(1):118-23. PubMed ID: 12596757
[TBL] [Abstract][Full Text] [Related]
4. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
[TBL] [Abstract][Full Text] [Related]
5. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
6. The evolution of assays for parathyroid hormone.
Goodman WG
Semin Dial; 2005; 18(4):296-301. PubMed ID: 16076352
[TBL] [Abstract][Full Text] [Related]
7. New PTH assays and renal osteodystrophy.
Salusky IB; Jüppner H
Pediatr Nephrol; 2004 Jul; 19(7):709-13. PubMed ID: 15173936
[TBL] [Abstract][Full Text] [Related]
8. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone: new assays, new receptors.
Martin KJ; Akhtar I; González EA
Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504
[TBL] [Abstract][Full Text] [Related]
11. The need for reliable serum parathyroid hormone measurements.
Torres PU
Kidney Int; 2006 Jul; 70(2):240-3. PubMed ID: 16838038
[TBL] [Abstract][Full Text] [Related]
12. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
[TBL] [Abstract][Full Text] [Related]
14. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
Gal-Moscovici A; Popovtzer MM
Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
[TBL] [Abstract][Full Text] [Related]
15. Practical considerations in PTH testing.
Souberbielle JC; Friedlander G; Cormier C
Clin Chim Acta; 2006 Apr; 366(1-2):81-9. PubMed ID: 16310759
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and recent advances in the management of renal osteodystrophy.
Elder G
J Bone Miner Res; 2002 Dec; 17(12):2094-105. PubMed ID: 12469904
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.
Godber IM; Parker CR; Lawson N; Hitch T; Porter CJ; Roe SD; Cassidy MJ; Hosking DJ
Ann Clin Biochem; 2002 May; 39(Pt 3):314-7. PubMed ID: 12038608
[TBL] [Abstract][Full Text] [Related]
18. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E
J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
[No Abstract] [Full Text] [Related]
19. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
Kakuta T; Ishida M; Fukagawa M
Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
[TBL] [Abstract][Full Text] [Related]
20. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
Coen G; Bonucci E; Ballanti P; Balducci A; Calabria S; Nicolai GA; Fischer MS; Lifrieri F; Manni M; Morosetti M; Moscaritolo E; Sardella D
Am J Kidney Dis; 2002 Aug; 40(2):348-54. PubMed ID: 12148108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
